Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional

OTO-413 in Subjects With Speech-in-Noise Hearing Impairment

ClinicalTrials.gov ID: NCT04129775

Public ClinicalTrials.gov record NCT04129775. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 10:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled Phase 1/2 Study of OTO-413 Given as a Single Intratympanic Injection in Subjects With Speech-in-noise Hearing Impairment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety, tolerability, and exploratory efficacy of OTO-413 administered as an intratympanic injection for the treatment of speech-in-noise hearing impairment.

Study identification

NCT ID
NCT04129775
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Otonomy, Inc.
Industry
Enrollment
110 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
21 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 1, 2019 (Actual)
Primary completion
Sep 5, 2022 (Actual)
Completion
Sep 5, 2022 (Actual)
Last update posted
Oct 27, 2022

2019 – 2022

United States locations

U.S. sites
8
U.S. states
6
U.S. cities
8
Facility City State ZIP Site status
Colorado Otolaryngology Associates LLC dba Colorado ENT & Allergy Colorado Springs Colorado 80923 —
Research Centers of America Hollywood Florida 33024 —
South Florida ENT Associates or Research Centers of America Miami Florida 33156 —
University of South Florida Tampa Florida 33612 —
Advanced ENT and Allergy, PLLC Louisville Kentucky 40220 —
Piedmont Ear, Nose & Throat Associates Winston-Salem North Carolina 27103 —
JBR Clinical Research Salt Lake City Utah 84107 —
Eastern Virginia Medical School, Department of Otolaryngology Norfolk Virginia 23507 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04129775, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 27, 2022 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04129775 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →